PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 2 days 15 hours 57 minutes
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale Is Compromised
Maintenance Therapy in COPD: Optimising Benefit With Inhalers When Ability to Inhale Is Compromised
Picturing a Different Future in CKD: A Call to Action
Picturing a Different Future in CKD: A Call to Action
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
Halting the Cascade of Chronic Kidney Disease: Can We Catch Patients Before They Fall?
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses
Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs
Shifting the Treatment Paradigm in Type 2 Diabetes and CKD: The Role of Nonsteroidal MRAs
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment
Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels
ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors